Literature DB >> 19482354

Primary myelofibrosis with concurrent precursor T-cell lymphoblastic lymphoma of the spleen in a 26-year-old patient.

Matjaz Sever, Jeffrey L Jorgensen, Inga Gurevich, Mariana Pinheiro, Srdan Verstovsek.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19482354      PMCID: PMC4406375          DOI: 10.1016/j.leukres.2009.05.005

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  16 in total

Review 1.  Update on T-cell lymphoma.

Authors:  J M Vose
Journal:  Ann Oncol       Date:  2008-06       Impact factor: 32.976

2.  Occurrence of spontaneous malignant lymphoma in the course of idiopathic myelofibrosis.

Authors:  G V Bogliolo; R A Lerza; C Ruggieri; I M Pannacciulli
Journal:  Am J Hematol       Date:  1988-03       Impact factor: 10.047

3.  Childhood myelofibrosis: transformation to acute lymphoblastic leukemia.

Authors:  R Ray; G Garewal; R K Marwaha; N Marwaha
Journal:  Pediatr Hematol Oncol       Date:  1993 Apr-Jun       Impact factor: 1.969

4.  Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia.

Authors:  Damiano Rondelli; Giovanni Barosi; Andrea Bacigalupo; Josef T Prchal; Uday Popat; Emilio P Alessandrino; Jerry L Spivak; B Douglas Smith; Hans G Klingemann; Steven Fruchtman; Ronald Hoffman
Journal:  Blood       Date:  2005-01-25       Impact factor: 22.113

Review 5.  Highly aggressive lymphomas in adults.

Authors:  John W Sweetenham
Journal:  Hematol Oncol Clin North Am       Date:  2008-10       Impact factor: 3.722

6.  Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.

Authors:  Ruben A Mesa; Chin-Yang Li; Rhett P Ketterling; Georgene S Schroeder; Ryan A Knudson; Ayalew Tefferi
Journal:  Blood       Date:  2004-09-23       Impact factor: 22.113

7.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Authors:  Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegard; Ruben Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Journal:  Blood       Date:  2007-05-08       Impact factor: 22.113

8.  Idiopathic myelofibrosis complicated by lymphoma. Report of two cases.

Authors:  R J Epstein; D E Joshua; H Kronenberg
Journal:  Acta Haematol       Date:  1985       Impact factor: 2.195

9.  Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia.

Authors:  A Polliack; M Prokocimer; Y Matzner
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047

10.  [Idiopathic myelofibrosis transformed to acute myelomonocytic leukemia associated with non-Hodgkin's lymphoma].

Authors:  M Kato; M Umeda; T Kosuge; S Anno; T Tsukahara; T Shirai
Journal:  Rinsho Ketsueki       Date:  1994-06
View more
  1 in total

1.  Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

Authors:  Stephen E Langabeer; Karl Haslam; David O'Brien; Johanna Kelly; Claire Andrews; Ciara Ryan; Richard Flavin; Patrick J Hayden; Christopher L Bacon
Journal:  Case Rep Hematol       Date:  2016-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.